An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
Synonyms
Carbamoyl oxime
Hydroxyharnstoff
Hydroxycarbamide
Hidroxicarbamida
Hydroxycarbamidum
Hydroxyurea
N-Hydroxyurea
N-Carbamoylhydroxylamine
Hydroxycarbamid
Carbamohydroximic acid
Carbamyl hydroxamate
Carbamohydroxamic acid
Oxyurea
Hydrea
Brand Names
Hydroxyurea
Hydrea
Siklos
Xromi
Droxia
Apo-hydroxyurea
Mylan-hydroxyurea
Riva-hydroxyurea
Indication
Hydroxyurea is indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in adult and pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises.[L41150]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682